No Result
View All Result
SUBMIT YOUR ARTICLES
  • Login
Wednesday, October 29, 2025
TheAdviserMagazine.com
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal
No Result
View All Result
TheAdviserMagazine.com
No Result
View All Result
Home Market Research Business

Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?

by TheAdviserMagazine
6 months ago
in Business
Reading Time: 4 mins read
A A
Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?
Share on FacebookShare on TwitterShare on LInkedIn


We recently compiled a list of the 10 Most Profitable Cheap Stocks to Buy Now. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against the other most profitable cheap stocks to buy.

US stocks rose on Friday, May 2, as the S&P 500, Dow Jones Industrial Average, and the tech-heavy Nasdaq all posted impressive gains. The S&P 500 added nearly 1.5% and this marked the ninth straight day of gains to mark the longest winning streak for the S&P 500 since November 2004. The Dow rose 1.4% to also report a ninth winning day in a row. Meanwhile, the Nasdaq gained roughly 1.5%.

READ ALSO: 13 Best Aggressive Growth Stocks to Buy Now and 14 Best American Tech Stocks To Buy Now.

The rally comes after China signaled openness to trade talks and a better-than-expected monthly US jobs report. In April, the US economy added 177,000 nonfarm payrolls, which was more than the 138,000 economists had expected. The unemployment rate remained steady at 4.2%. This data indicated resiliency in the labor market despite stock market uncertainty in April due to tariff concerns.

Investors were also encouraged by indications that the US-China trade war could be easing. On Friday, China said it is evaluating recent US proposals for trade talks to see how serious Trump’s administration is about a change in policy stance. China’s commerce minister stated that the “door is open” if the US would agree to pull back on reciprocal tariffs. These comments helped reduce concerns about the risk of an economic slowdown by the tariffs.

Overall, hopes for improved US-China relations combined with solid job growth helped boost confidence on Wall Street.

To compile our list of the 10 most profitable cheap stocks to buy now, we used the Finviz stock screener to find stocks with a forward P/E ratio of less than 15. We sorted our results based on market capitalization and picked the top 25 cheap stocks trading at under 15 times their forward earnings as of April 29, 2025. Next, we focused on profitability and narrowed our choices to stocks that had trailing twelve-month (TTM) net income of more than $1 billion. Finally, we focused on the top 10 profitable stocks most favored by institutional investors. Data for the hedge fund sentiment surrounding each stock was taken from Insider Monkey’s Q4 2024 database of more than 1,000 elite hedge funds. The 10 most profitable cheap stocks to buy now were then ranked in ascending order based on the number of hedge funds holding stakes in them as of Q4 2024.

Why do we care about what hedge funds do? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).

Story Continues

Is Merck & Co., Inc. (MRK) The Most Profitable Cheap Stock to Buy Now?

A close-up of a person’s hand holding a bottle of pharmaceuticals.

Forward P/E: 9.45

TTM Net Income: $17.11 Billion

Number of Hedge Fund Holders: 91

Merck & Co., Inc. (NYSE:MRK), known as MSD outside the United States and Canada, is one of the largest pharmaceutical companies in the world. It offers innovative health solutions through its prescription medicines, vaccines, biologic therapies, and animal health products. Merck & Co., Inc. (NYSE:MRK) is one of the most profitable stocks to invest in.

The company is actively working to expand and diversify its pipeline and increase its manufacturing capacity for next-generation therapies. In March 2025, Merck & Co., Inc. (NYSE:MRK) announced the completion of a $1 billion, 225,000-square-foot state-of-the-art facility in Durham, North Carolina. The new manufacturing facility, aimed at enhancing the company’s vaccine production capacity, uses the best practices from the company’s manufacturing network and includes new technologies and digital capabilities like data analytics, generative AI, and 3D printing. On April 29, Merck & Co., Inc. (NYSE:MRK) announced the start of construction for another $1 billion, 470,000-square-foot biologics center of excellence in Wilmington, Delaware. The new center will have laboratory, manufacturing, and warehouse capabilities to support the development and production of next-generation biologics and therapies including potent antibody-drug conjugates (ADCs). The Wilmington Biotech site will also have the capability to produce KEYTRUDA (pembrolizumab). Merck & Co., Inc. (NYSE:MRK) aims to establish the site as the future home in the US for manufacturing KEYTRUDA for patients in the US. The site’s laboratory component is expected to be fully operational by 2028 and the production of investigational compounds is expected to start by 2030.

Overall, MRK ranks 9th on our list of the most profitable cheap stocks to buy now. While we acknowledge the potential of MRK as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than MRK but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

 

READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.

 

Disclosure: None. This article is originally published at Insider Monkey.



Source link

Tags: BuycheapMerckMRKProfitablestock
ShareTweetShare
Previous Post

Worldcoin Ordered to Delete Biometric Data in Kenya Over Privacy Breach

Next Post

Chinese cars increase market share in Israel in 2025

Related Posts

edit post
Akasa Air will look at IPO in next 2-5 years, says CEO Vinay Dube

Akasa Air will look at IPO in next 2-5 years, says CEO Vinay Dube

by TheAdviserMagazine
October 29, 2025
0

Akasa Air will look at an initial public offering in the next two to five years, its Founder and CEO...

edit post
Copper hits record on mine supply issues, US-China tension easing boosts rally

Copper hits record on mine supply issues, US-China tension easing boosts rally

by TheAdviserMagazine
October 29, 2025
0

Oct. 29, 2025 6:34 AM ETCopper Futures (HG1:COM), COPX, CPERFCX, SCCO, BHP, TECK, RIO, AAUKF, GLCNF, HBM, NGLOY, EROBy: Arundhati...

edit post
How Bupa’s CEO Iñaki Ereño woke a sleeping giant—and set a 100,000 strong workforce running toward digital health 

How Bupa’s CEO Iñaki Ereño woke a sleeping giant—and set a 100,000 strong workforce running toward digital health 

by TheAdviserMagazine
October 29, 2025
0

CEO Agenda provides unique insights into how leaders think and lead and what keeps them busy in a world of...

edit post
Metal sector remains a trading play, not a structural Bet: Dhananjay Sinha

Metal sector remains a trading play, not a structural Bet: Dhananjay Sinha

by TheAdviserMagazine
October 29, 2025
0

In an exclusive conversation with ET Now, Dhananjay Sinha from Systematix Group shared his perspective on the ongoing market trends,...

edit post
Asian stocks: Asian stocks open higher as AI, Fed lift sentiment

Asian stocks: Asian stocks open higher as AI, Fed lift sentiment

by TheAdviserMagazine
October 28, 2025
0

Asian stocks opened higher, buoyed by Wall Street optimism that artificial intelligence will keep fueling profits at major technology firms...

edit post
OrthoPediatrics outlines path to 12% baseline growth and free cash flow breakeven by 2026 amid clinic expansion and strong T&D momentum (NASDAQ:KIDS)

OrthoPediatrics outlines path to 12% baseline growth and free cash flow breakeven by 2026 amid clinic expansion and strong T&D momentum (NASDAQ:KIDS)

by TheAdviserMagazine
October 28, 2025
0

Seeking Alpha's Disclaimer: The earnings call insights are compilations of earnings call transcripts and other content available on the Seeking...

Next Post
edit post
Chinese cars increase market share in Israel in 2025

Chinese cars increase market share in Israel in 2025

edit post
Thank You, Mr. Buffett | Stock Gumshoe

Thank You, Mr. Buffett | Stock Gumshoe

  • Trending
  • Comments
  • Latest
edit post
77-year-old popular furniture retailer closes store locations

77-year-old popular furniture retailer closes store locations

October 18, 2025
edit post
Pennsylvania House of Representatives Rejects Update to Child Custody Laws

Pennsylvania House of Representatives Rejects Update to Child Custody Laws

October 7, 2025
edit post
What to Do When a Loved One Dies in North Carolina

What to Do When a Loved One Dies in North Carolina

October 8, 2025
edit post
Another Violent Outburst – Democrats Inciting Civil Unrest

Another Violent Outburst – Democrats Inciting Civil Unrest

October 24, 2025
edit post
Probate vs. Non-Probate Assets: What’s the Difference?

Probate vs. Non-Probate Assets: What’s the Difference?

October 17, 2025
edit post
California Attorney Pleads Guilty For Role In 2M Ponzi Scheme

California Attorney Pleads Guilty For Role In $912M Ponzi Scheme

October 15, 2025
edit post
Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments

Cytokinetics has been on a tear as the biotech pioneers more drugs to fight heart ailments

0
edit post
Akasa Air will look at IPO in next 2-5 years, says CEO Vinay Dube

Akasa Air will look at IPO in next 2-5 years, says CEO Vinay Dube

0
edit post
Southwest’s New Debit Card Lets You Earn Points

Southwest’s New Debit Card Lets You Earn Points

0
edit post
Here are the 5 Startup Battlefield finalists at TechCrunch Disrupt 2025

Here are the 5 Startup Battlefield finalists at TechCrunch Disrupt 2025

0
edit post
Meta Earnings Preview: All Eyes on AI Monetization, Capex Ahead of Key Report

Meta Earnings Preview: All Eyes on AI Monetization, Capex Ahead of Key Report

0
edit post
Extending Inherited IRA Distributions Beyond 10 Years By Naming Intentionally Non-Designated Beneficiaries

Extending Inherited IRA Distributions Beyond 10 Years By Naming Intentionally Non-Designated Beneficiaries

0
edit post
Extending Inherited IRA Distributions Beyond 10 Years By Naming Intentionally Non-Designated Beneficiaries

Extending Inherited IRA Distributions Beyond 10 Years By Naming Intentionally Non-Designated Beneficiaries

October 29, 2025
edit post
Akasa Air will look at IPO in next 2-5 years, says CEO Vinay Dube

Akasa Air will look at IPO in next 2-5 years, says CEO Vinay Dube

October 29, 2025
edit post
Meta Earnings Preview: All Eyes on AI Monetization, Capex Ahead of Key Report

Meta Earnings Preview: All Eyes on AI Monetization, Capex Ahead of Key Report

October 29, 2025
edit post
Copper hits record on mine supply issues, US-China tension easing boosts rally

Copper hits record on mine supply issues, US-China tension easing boosts rally

October 29, 2025
edit post
How Bupa’s CEO Iñaki Ereño woke a sleeping giant—and set a 100,000 strong workforce running toward digital health 

How Bupa’s CEO Iñaki Ereño woke a sleeping giant—and set a 100,000 strong workforce running toward digital health 

October 29, 2025
edit post
How Tariffs Hurt the Ones You Love

How Tariffs Hurt the Ones You Love

October 29, 2025
The Adviser Magazine

The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.

CATEGORIES

  • 401k Plans
  • Business
  • College
  • Cryptocurrency
  • Economy
  • Estate Plans
  • Financial Planning
  • Investing
  • IRS & Taxes
  • Legal
  • Market Analysis
  • Markets
  • Medicare
  • Money
  • Personal Finance
  • Social Security
  • Startups
  • Stock Market
  • Trading

LATEST UPDATES

  • Extending Inherited IRA Distributions Beyond 10 Years By Naming Intentionally Non-Designated Beneficiaries
  • Akasa Air will look at IPO in next 2-5 years, says CEO Vinay Dube
  • Meta Earnings Preview: All Eyes on AI Monetization, Capex Ahead of Key Report
  • Our Great Privacy Policy
  • Terms of Use, Legal Notices & Disclosures
  • Contact us
  • About Us

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • Financial Planning
    • Financial Planning
    • Personal Finance
  • Market Research
    • Business
    • Investing
    • Money
    • Economy
    • Markets
    • Stocks
    • Trading
  • 401k Plans
  • College
  • IRS & Taxes
  • Estate Plans
  • Social Security
  • Medicare
  • Legal

© Copyright 2024 All Rights Reserved
See articles for original source and related links to external sites.